|
It was reported that on (b)(6) 2026, a 25mm amplatzer cribriform occluder was chosen for implant.The defect characteristics were reported as a tunnel measuring 12 mm, an aortic rim >5 mm, and aneurysm excursion of approximately 1 mm.Device sizing was determined using transesophageal echocardiography (tee), and tee was also used as the imaging modality during the procedure.During post-procedure follow-up on (b)(6) 2026, the implanted device was found to be malpositioned.The migration/malposition was identified at follow-up by transthoracic echocardiogram.No clinical signs or symptoms were reported during or after the event.As a result, percutaneous withdrawal of the device was performed successfully.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects reported.
|